{"podcast":{"title":"BioSpace","slug":"biospace-6696251","podcast_index_feed_id":6696251,"rss_url":"https://api.riverside.fm/hosting/3SxyDAXU.rss","website_url":"https://www.biospace.com/","image_url":"https://hosting-media.riverside.com/media/imports/podcasts/a2a52916-bfe1-4f2a-b9a3-9be5029ecbe4/39510587-1699400129885-1e919ae7cb2aa.jpg","author":"BioSpace","episode_count":247,"summary":"Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.","last_synced_at":"2026-07-15T16:19:04.105662+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251"},"episode":{"title":"The next era of diabetes management","slug":"the-next-era-of-diabetes-management","published_at":"2026-04-23T07:50:23+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/the-next-era-of-diabetes-management","show_page_url":"https://stenobird.com/podcast/biospace-6696251","url":"https://api.riverside.com/hosting-analytics/media/7e7cc274bdf350b388b06c34c022a86a40c6aa201ec34db0dd49c372372dfcaa/eyJlcGlzb2RlSWQiOiI3NWU4MGRmNC1hMDE3LTQ3ZTItYTQwOS0zOWI5M2UxNWNjYzMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjllOWNmM2Y2ZmRjMTExNjcxOTc4NDQ1L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTIzX185LTUwLTIzLm1wMyJ9.mp3","audio_url":"https://api.riverside.com/hosting-analytics/media/7e7cc274bdf350b388b06c34c022a86a40c6aa201ec34db0dd49c372372dfcaa/eyJlcGlzb2RlSWQiOiI3NWU4MGRmNC1hMDE3LTQ3ZTItYTQwOS0zOWI5M2UxNWNjYzMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNjllOWNmM2Y2ZmRjMTExNjcxOTc4NDQ1L2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi00LTIzX185LTUwLTIzLm1wMyJ9.mp3","summary":"In this episode of Denatured, you'll be hearing from Dr. Sarah Howell, CEO at Arecor Therapeutics and Dr. Wendy S. Lane, clinical endocrinologist and diabetologist. We examine how increasingly connected and tailored diabetes technologies are reframing the field’s central opportunity around minimizing the day-to-day demands of managing the condition.","meta_description":"In this episode of Denatured, you'll be hearing from Dr. Sarah Howell, CEO at Arecor Therapeutics and Dr. Wendy S. Lane, clinical endocrinologist and diab…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1302,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/the-next-era-of-diabetes-management/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/the-next-era-of-diabetes-management.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}